Proprium Biotech closes multi-million-yuan Series A, focuses on liver disease diagnosis

Proprium Biotech, a quasi-unicorn enterprise in the field of liver disease diagnosis, announced that it has raised tens of millions of yuan in its Series A financing round led by Neovision Capital.

Proprium Biotech, a quasi-unicorn enterprise in the field of liver disease diagnosis, announced that it has raised tens of millions of yuan in its Series A financing round led by Neovision Capital.

Proceeds from the fresh funding round will be mainly used for the marketing of the company’s core product CHI3L1 and the expansion of Chinese and overseas channels.

Established in 2010, Proprium Biotech has personalized medical diagnostic technology in the fields of liver cancer, liver fibrosis and more. It holds completely proprietary intellectual property rights and has successfully developed a variety of new diagnostic products based on this technology.

The company is committed to building an innovative platform for testing reagents, supporting testing instruments and diagnosis, and realizing clinical diagnosis including precise diagnosis of liver diseases and personalized medicine.

Since its inception, Proprium Biotech has focused on the field of liver disease diagnosis and devotes itself to research and development. The company has successively completed the development of several national exclusive products including CHI3L1, liver cancer triple detection etc.

CHI3L1 provides more sensitive markers for staging and dynamic monitoring of liver fibrosis, and timely and effective screening and identification of potential liver fibrosis without obvious symptoms, which solves some difficulties in the field of liver disease diagnosis and make up for the market gap of accurate and quantitative detection of liver fibrosis.

Disclaimer: This is an article created by Michael Liang for Chinasdg.org. You can find the original article here: https://chinasdg.org/2020/05/26/proprium-biotech-closes-multi-million-yuan-series-a-focuses-on-liver-disease-diagnosis/.

Leave a Reply

Please Login to Comment